Aminoacetaldehyde → 3-[[5-Chloro-4-(2,3-dihydro-2-oxo-1H-imidazol-1-yl)-2-methoxyphenyl]-methyl]-5-[4-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2(3H)-one

HRID 362460

반응식

HRID 362460 반응식
[NH2:1][C:2]1[C:7]([Cl:8])=[CH:6][C:5]([CH2:9][N:10]2[N:14]=[C:13]([C:15]3[CH:20]=[CH:19][C:18]([C:21]([F:24])([F:23])[F:22])=[CH:17][CH:16]=3)[O:12][C:11]2=[O:25])=[C:4]([O:26][CH3:27])[CH:3]=1.[CH2:28]([N:30]([CH2:33]C)CC)[CH3:29].C(Cl)(Cl)=[O:36].NCC=O.[K+].[Br-]>C1COCC1.C1(C)C=CC=CC=1.C(OCC)C.ClCCl>[Cl:8][C:7]1[C:2]([N:1]2[CH:29]=[CH:28][NH:30][C:33]2=[O:36])=[CH:3][C:4]([O:26][CH3:27])=[C:5]([CH2:9][N:10]2[N:14]=[C:13]([C:15]3[CH:16]=[CH:17][C:18]([C:21]([F:22])([F:24])[F:23])=[CH:19][CH:20]=3)[O:12][C:11]2=[O:25])[CH:6]=1

참가 물질

10

반응물 5

HCID 363AminoacetaldehydeHCID 6371PhosgeneHCID 8471TriethylamineHCID 253877Potassium BromideHCID 161056143-[(4-Amino-5-chloro-2-methoxyphenyl)methyl]-5-[4-(trifluoromethyl) phenyl]-1,3,4-oxadiazol-2(3H)-one

생성물 1

HCID 158387823-[[5-Chloro-4-(2,3-dihydro-2-oxo-1H-imidazol-1-yl)-2-methoxyphenyl]-methyl]-5-[4-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2(3H)-one

시약·촉매·용매 4

HCID 1140Toluene용매HCID 3283Diethyl Ether용매HCID 6344Dichloromethane용매HCID 8028Tetrahydrofuran용매

반응 조건

온도
24 °C

실험 절차

3-[(4-Amino-5-chloro-2-methoxyphenyl)methyl]-5-[4-(trifluoromethyl) phenyl]-1,3,4-oxadiazol-2(3H)-one (1.14 g, 2.9 mmol) and triethylamine (1.0 ml, 6.8 mmol) were taken up in anhydrous THF (20 ml) and transferred dropwise by cannula into a 20% solution of phosgene in toluene at 0° C. under N2. The reaction was stirred 2.5 h at 24° C., diluted with diethylether (1 vol), and filtered through a celite plug. Concentrated by rotary evaporation to gave a solid which was dissolved in dichloromethane (50 ml) under N2 and aminoacetaldehyde (0.42 ml, 2.9 mmol) was added. The solution was stirred 3 h and concentrated to remove solvent. The residue was taken up in 25 ml of formic acid (88%) and stirred 18 h at 24° C. The formic acid was removed by rotary evaporation the residue taken up in ethyl acetate, washed with saturated NaHCO3 solution and brine, and dried. Concentration on SiO2, and elution with 45% THF/benzene gave 850 mg (65%). mp 201°-202° C.; IR(KBr, ν=cm-1) 3414, 1792, 1694, 1330, 1236, 1136; 1H NMR (300 MHz, CDCl3) δ3.86 (3H, s), 4.97 (2H, s), 6.38 (2H, br, s), 6.99 (1H, s), 7.40 (1H, s), 7.71 (2H, d, J=8.4 Hz), 7.94 (2H, d, J=8.2 Hz), 10.28 (1H, br, s); MS(ESI)m/z: 465 (M--H-)

후처리

  1. filtrationfiltered through a celite plug
  2. concentrationConcentrated by rotary evaporation
  3. customto gave a solid which
  4. stirringThe solution was stirred 3 h
  5. concentrationconcentrated
  6. customto remove solvent
  7. stirringstirred 18 h at 24° C
  8. customThe formic acid was removed by rotary evaporation the residue
  9. washwashed with saturated NaHCO3 solution and brine
  10. customdried
  11. concentrationConcentration
  12. washon SiO2, and elution with 45% THF/benzene
  13. customgave 850 mg (65%)

출처 및 근거

ORD 기록
ord-71a76c14311e4eaca5a077c194dd92a8
출처 데이터셋
uspto-grants-1999_02
특허 번호
US05869509

연결된 노트

불러오는 중…